Paper 1: The EUROCAT network-organization and processes

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 91, Issue SUPPL. 1, 2011, Pages

  Boyd, Patricia A ^a   Haeusler, Martin ^b   Barisic, Ingeborg ^c   Loane, Maria ^d   Garne, Ester ^e   Dolk, Helen ^d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d UNIVERSITY OF ULSTER   (United Kingdom)

^e KOLDING HOSPITAL   (Denmark)

Author keywords

Congenital anomalies; Epidemiology; EUROCAT; Prenatal screening; Prevalence; Prevention; Registries; Surveillance

Indexed keywords

FOLIC ACID;

CONFIDENTIALITY; CONGENITAL MALFORMATION; DATA BASE; DISEASE CLASSIFICATION; DRUG USE; ETHICS; EUROPE; EUROPEAN SURVEILLANCE OF CONGENITAL ANOMALIES; HEALTH SURVEY; HUMAN; INFORMATION RETRIEVAL; INFORMATION STORAGE; INTERNET; METHODOLOGY; MONITORING; ORGANIZATION; PATIENT CODING; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; REGISTER; REVIEW; STATISTICAL ANALYSIS;

CONGENITAL ABNORMALITIES; DATABASES, FACTUAL; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; POPULATION SURVEILLANCE; PREGNANCY; PRENATAL DIAGNOSIS; PREVALENCE; REGISTRIES;

EID: 79952633042     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20780     Document Type: Review

References (24)

1. Boyd PA, de Vigan C, Khoshnood B, et al. 2008. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 115: 689-96.
2. Boyd PA, Loane C, Garne E, Khoshnood B, et al. 2010. Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet 19: 231-234.
3. Busby A, Abramsky L, Armstrong B, et al. 2005a. Preventing neural tube defects in Europe: a missed opportunity. Reprod Toxicol 20: 393-402.
4. Busby A, Abramsky L, Dolk H, et al. 2005b. Preventing neural tube defects in Europe: population based study. BMJ 330: 574-575.
5. Dolk H, Lechat M. 1993. Health surveillance in Europe: Lessons from EUROCAT and Chernobyl. Int J Epidemiol 22: 363-368.
6. Dolk H, Vrijheid M, Armstrong B, et al. 1998. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet 352: 423-427.
7. Dolk H. 2005. EUROCAT: 25 years of European surveillance of congenital anomalies. Arch Dis Child Fetal Neonatal Ed 90: F355-F358.
8. Dolk H, Jentink J, Loane MA, et al. 2008. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 71: 714-22.
9. Dolk H. 2009. What is the "Primary" Prevention of Congenital Anomalies? Lancet 372: 378.
10. Dolk H, Loane MA, Abramsky L, et al. 2010. Birth prevalence of congenital heart disease. Epidemiology 212: 275-277.
11. EUROCAT. 2005. EUROCAT Guide 1.3: Instruction for the registration of congenital anomalies. EUROCAT Central Registry, University of Ulster, Belfast.
12. EUROCAT. 2008. EUROCAT Statistical Monitoring Report 2005. EUROCAT Central Registry, University of Ulster.
13. EUROCAT. 2008. EUROCAT Statistical Monitoring Protocol. EUROCAT Central Registry, University of Ulster.
14. EUROCAT. 2009. Special Report: Prevention of neural tube defects by periconceptional folic acid supplementation in Europe. University of Ulster: EUROCAT Central Registry.
15. EUROCAT. 2009. EUROCAT Statistical Monitoring Report 2006. EUROCAT Central Registry, University of Ulster.
16. EUROCAT. 2010. EUROCAT Special Report: Prenatal screening policies in Europe 2010. EUROCAT Central Registry, University of Ulster.
17. Garne E, Loane M, Dolk H, et al. 2005. Prenatal diagnosis of severe structural malformations in Europe. Ultrasound Obstet Gynecol 25: 6-11.
18. Garne E, Loane M, Nelen V, et al. 2007. Survival and health in liveborn infants with transposition of great arteries-a population-based study. Congenit Heart Dis 2: 165-9.
19. Garne E, Dolk H, Loane M, et al. 2010a. EUROCAT website data on prenatal detection rates of congenital anomalies. J Med Screen 17: 97-98.
20. Garne E, Khoshnood B, Loane M, et al. 2010b. Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European register-based study. BJOG 117: 660-666.
21. Jentink J, Loane MA, Dolk H, et al. 2010. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362: 2185-93.
22. Medical Research Council Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
23. Smithells RW, Sheppard S, Schorah CJ, et al. 1980. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1: 339-340.
24. Weatherall J. 1985. The beginnings of EUROCAT. Louvain-la-Neuve, Cabay.